Daybreak Well being secures $13M for international enlargement
Copenhagen-based digital well being firm specializing in persistent illness administration, Daybreak Well being secured $13 million (€11.5 million) from current traders Chr. Augustinus Fabrikker, the export and funding fund of Denmark (EIFO) and Trifork.
WHAT IT DOES
Daybreak Well being’s platform and merchandise are utilized in oncology, a number of sclerosis and for uncommon pediatric circumstances, like progress issues, to assist pharma firms, sufferers and healthcare professionals increase outcomes and affected person care by leveraging superior capabilities in AI, information, proof technology, scientific integrations, personalization and related well being.
Merck and Novartis are among the many firms which have adopted Daybreak’s choices.
The corporate will use the funds to market its platform and product suite to international pharmaceutical firms by means of a SaaS mannequin.
“Our ambition is to be the worldwide chief in digital well being, powering pharma’s next-generation merchandise and in the end enhancing the lives of sufferers worldwide,” Alexander Mandix Hansen, CEO of Daybreak Well being, mentioned in a press release.
“This funding permits us to carry our confirmed platform to extra markets and deepen our influence.”
MARKET SNAPSHOT
In 2023, Daybreak Well being partnered with Novartis to develop a persistent situation administration platform.
Below the collaboration, Daybreak and Novartis constructed distant monitoring and administration instruments for persistent circumstances the place they see an unmet want and issues round illness development, like a number of sclerosis, hypertension, heart problems and breast most cancers.
The platform contains affected person cellular apps, symptom monitoring, digital biomarkers, scientific resolution assist companies and digital clinic choices geared towards particular ailments and circumstances.
Different firms within the persistent situation area embrace Wellth, which secured $20 million in Collection B funding in 2023.
The spherical was led by SignalFire, with participation from former Evolent Well being CEO Frank Williams and former traders the Social Entrepreneurs’ Fund, CD Enterprise, Yabeo and the Partnership Fund for NYC.
In 2022, Omada Well being included behavioral well being assist in its current packages for diabetes prevention and administration, hypertension and musculoskeletal care.
The behavioral well being integration contains nervousness and despair evaluation, sources to handle social determinants of well being, stress administration and sleep instruments. It gives care groups supplemented by psychological well being specialists and coaching, triage and steerage in severe psychological well being crises.
That very same yr, the corporate raised a hefty $192 million in Collection E funding, which it used to put money into new hires, its tech street map for care personalization and its Omada Insights Lab.
Constancy Administration & Analysis Firm led the spherical, which included participation from aMoon, Perceptive Advisors, Wellington Administration, Civilization Ventures and others.
